About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• 'ART as prevention tool' policy announced for British Columbia
• <i>The Lancet</i>: HIV is a global disaster
• Important changes to nevirapine dosing advice made by FDA
• Fatty liver in patients with HIV associated with metabolic abnormalities
• Most HIV infections in Zambia and Rwanda happen in marriage: prevention programmes for couples recommended
• HIV-positive Caribbean people in the UK experience high levels of stigma
• Poverty and unemployment common amongst HIV-positive Londoners
• Risk of death for people with HIV now similar to that seen in the general population
• Simple, cheap test an accurate measure of hardening of the arteries in patients with HIV
• Asymptomatic anal HPV infection more common than thought in heterosexual men